Caris Life Sciences Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| J. H. WHITNEY EQUITY PARTNERS VI, LLC | 02/13/2026 | 20.26 M | $546.52 M | 100.00% | 7.18% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 02/17/2026 | 19.39 M | $523.02 M | -20.50% | 6.87% |
| FMR LLC | 02/17/2026 | 14.22 M | $383.60 M | 47.59% | 5.04% |
| COATUE MANAGEMENT LLC | 02/17/2026 | 9.82 M | $264.94 M | -3.18% | 3.48% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/19/2026 | 9.21 M | $248.38 M | 14.71% | 3.26% |
| BRAIDWELL LP | 02/17/2026 | 7.82 M | $210.88 M | 6.83% | 2.77% |
| POINTSTATE CAPITAL LP | 02/17/2026 | 6.72 M | $181.27 M | 73.00% | 2.38% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 4.83 M | $130.26 M | -30.28% | 1.71% |
| NEUBERGER BERMAN GROUP LLC | 02/13/2026 | 3.80 M | $102.55 M | -12.52% | 1.35% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 3.65 M | $98.55 M | -7.25% | 1.29% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 3.12 M | $84.07 M | 2.67% | 1.10% |
| CITADEL ADVISORS LLC | 02/17/2026 | 3.11 M | $84.01 M | 100.00% | 1.10% |
| JPMORGAN CHASE & CO | 02/11/2026 | 2.45 M | $65.97 M | 184.96% | 0.87% |
| BLACKROCK, INC. | 02/12/2026 | 2.37 M | $63.98 M | 266.45% | 0.84% |
| UBS GROUP AG | 01/29/2026 | 2.18 M | $58.92 M | 825.91% | 0.77% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 1.86 M | $50.31 M | 656.16% | 0.66% |
| MORGAN STANLEY | 02/13/2026 | 1.79 M | $48.43 M | 16.98% | 0.64% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 1.66 M | $44.79 M | 23,902.89% | 0.59% |
| LONGAEVA PARTNERS L.P. | 02/17/2026 | 1.51 M | $40.73 M | 17.40% | 0.54% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 1.51 M | $40.61 M | -10.38% | 0.53% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 1.47 M | $39.67 M | 31.72% | 0.52% |
| CANADA PENSION PLAN INVESTMENT BOARD | 02/17/2026 | 1.46 M | $39.51 M | 10.72% | 0.52% |
| CLEARBRIDGE INVESTMENTS, LLC | 02/11/2026 | 1.42 M | $38.21 M | 2.53% | 0.50% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 1.14 M | $30.65 M | 3.46% | 0.40% |
| FIL LTD | 02/17/2026 | 1.12 M | $30.29 M | 396.98% | 0.40% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.12 M | $30.29 M | 161.42% | 0.40% |
| INVESCO LTD. | 02/19/2026 | 1.03 M | $27.87 M | 28.53% | 0.37% |
| MARSHALL WACE, LLP | 02/13/2026 | 1.00 M | $27.05 M | 1,108.48% | 0.36% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 01/22/2026 | 941.64 K | $25.41 M | -3.06% | 0.33% |
| CHAMPLAIN INVESTMENT PARTNERS, LLC | 02/13/2026 | 939.37 K | $25.34 M | 100.00% | 0.33% |
| GHISALLO CAPITAL MANAGEMENT LLC | 02/17/2026 | 845.33 K | $22.81 M | -19.35% | 0.30% |
| TD ASSET MANAGEMENT INC | 02/10/2026 | 773.85 K | $20.88 M | 248.06% | 0.27% |
| WOODLINE PARTNERS LP | 02/17/2026 | 723.16 K | $19.51 M | 0.00% | 0.26% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 687.50 K | $18.55 M | -13.38% | 0.24% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 685.83 K | $18.50 M | 57,052.17% | 0.24% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 01/15/2026 | 543.19 K | $14.66 M | 100.00% | 0.19% |
| SEVEN GRAND MANAGERS, LLC | 02/10/2026 | 495.10 K | $13.36 M | 395.10% | 0.18% |
| ARK INVESTMENT MANAGEMENT LLC | 02/11/2026 | 408.73 K | $11.03 M | 66.59% | 0.14% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 372.98 K | $10.06 M | -6.36% | 0.13% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 350.14 K | $9.45 M | 24.07% | 0.12% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 329.90 K | $8.90 M | 46.56% | 0.12% |
| MERIDIEM CAPITAL PARTNERS LP | 02/17/2026 | 278.06 K | $7.50 M | 100.00% | 0.10% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 268.62 K | $7.25 M | 23.81% | 0.10% |
| STATE STREET CORP | 02/13/2026 | 260.65 K | $7.03 M | 67.79% | 0.09% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/17/2026 | 247.41 K | $6.68 M | 100.00% | 0.09% |
| LAZARD ASSET MANAGEMENT LLC | 02/17/2026 | 242.78 K | $6.55 M | -12.52% | 0.09% |
| HOLOCENE ADVISORS, LP | 02/17/2026 | 237.90 K | $6.42 M | 39.02% | 0.08% |
| PICTON MAHONEY ASSET MANAGEMENT | 02/11/2026 | 218.31 K | $5.89 M | 3,415.38% | 0.08% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 206.99 K | $5.58 M | 532.00% | 0.07% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 200.00 K | $5.40 M | 100.00% | 0.07% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Caris Life Sciences Inc. institutional Ownership - FAQ's
During the previous two years, 271 institutional investors and hedge funds held shares of Caris Life Sciences Inc.. The most heavily invested institutionals were:
J. H. Whitney Equity Partners VI, LLC: 18.26 M
UBS Group AG: 2.75 M
LOS ANGELES CAPITAL MANAGEMENT LLC: 2.29 M
BNP PARIBAS ARBITRAGE, SNC: 1.61 M
Invesco Ltd.: 1.22 M
TD ASSET MANAGEMENT INC: 670,388
51.46% of Caris Life Sciences Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 171.13 M shares in the last 24 months. This purchase volume represents approximately $3.25 B in transactions.